Introduction
============

Articular cartilage facilitates joint loading and movement by resisting compressive and shear forces ([@ref-59]). For patients, localized cartilage defects can have detrimental long term effects such as joint dysfunction, pain, and degenerative osteoarthritis. Upon cartilage damage, its avascular nature prevents spontaneous healing ([@ref-8]). Clinical treatments for full-thickness cartilage defects and osteochondral lesions include bone marrow stimulation techniques, e.g., microfracture and subchondral drilling, and autologous chondrocyte implantation. Defect size generally determines treatment, where microfracture and autologous chondrocyte implantation are used to treat small (\<2.5 cm^2^) and large lesions (\>2.5 cm^2^), respectively ([@ref-15]). Microfracture surgery is a minimally invasive and inexpensive one-step approach, where multiple perforations, microfractures, are made in the subchondral bone plate to induce bleeding and provoke a reparative response. The formed blood clot consists of bone marrow-derived mesenchymal stem cells (BM-MSCs), growth factors and other proteins, supporting cartilage formation ([@ref-58]). The repaired tissue, however, generally consists of fibrous cartilage, which lacks the mechanical properties of native hyaline cartilage ([@ref-16]). Microfracture results in temporary clinical improvement only ([@ref-51]), and the demand for improved cartilage regeneration persists.

Cartilage regeneration may be improved by tissue engineering and regenerative medicine (TERM) in addition to bone marrow stimulating techniques. TERM encompasses the development of biomaterials, which can be loaded with cells and biologics ([@ref-54]). Upon implantation and infiltration of BM-MSCs, the biomaterial may act as a template to guide/stimulate cartilage regeneration ([@ref-15]). In a previous systematic review and meta-analysis on animal models, we showed that acellular biomaterials in addition to bone marrow stimulation was more effective in regenerating cartilage *in vivo* than bone marrow stimulation alone, which was further improved by use of biologics ([@ref-48]).

When biomaterials are loaded with cells, bone marrow stimulation may be even more effective. Biomaterials loaded with cells after bone marrow stimulation has been widely investigated *in vivo*, and included loading of chondrocytes ([@ref-2]; [@ref-9]; [@ref-11]), BM-MSCs ([@ref-3]; [@ref-35]; [@ref-63]), synovium-derived mesenchymal stem cells (SD-MSCs) ([@ref-46]; [@ref-39]; [@ref-55]), adipose-derived stem cells (ADSCs) ([@ref-66]; [@ref-43]; [@ref-36]), periosteal cells ([@ref-47]; [@ref-52]), fibroblasts ([@ref-67]), umbilical cord stem cells (UCSC) ([@ref-67]; [@ref-13]) and embryonic stem cells (ESC) ([@ref-10]). Cells are either used directly after harvesting ([@ref-7]; [@ref-23]) or after an additional *in vitro* step of cell expansion ([@ref-24]; [@ref-21]) and/or differentiation ([@ref-57]; [@ref-44]).

In this systematic review and meta-analysis, we present a comprehensive overview of all current literature regarding regeneration of articular cartilage by implantation of cell-laden versus cell-free biomaterials in the knee and ankle joint after bone marrow stimulation in animal models ([Fig. 1](#fig-1){ref-type="fig"}). We further investigated the effect of loading biomaterials with (1) stem cells versus somatic (differentiated) cells, (2) different cell types (e.g., chondrocytes, MSCs, ADSCs), and (3) culture conditions of cells (e.g., use after harvesting, *in vitro* expansion and/or differentiation). In the meta-analysis, histological scores from semi-quantitative histological scoring systems were used to assess the effect on cartilage regeneration.

![Illustration of articular cartilage regeneration by implantation of cellular and acellular biomaterials after applying bone marrow stimulation.\
The figure was adapted from [@ref-48].](peerj-05-3927-g001){#fig-1}

Materials and Methods
=====================

Search strategy
---------------

An extensive literature search was performed in PubMed and EMBASE (via OvidSP) to identify relevant peer-reviewed articles until June 29, 2016, using methods defined by [@ref-17] and [@ref-41]. The search strategy ([Supplemental Information 1](#supp-3){ref-type="supplementary-material"}) consisted of search components for tissue engineering ([@ref-56]) and cartilage ([@ref-48]). Results were refined for animal studies by applying animal search filters ([@ref-33]; [@ref-18]). No language restrictions were applied.

Study selection
---------------

After obtaining all references, duplicates were manually removed in EndNote X7 (Thomson Reuters, Philadelphia, PA, USA) by one author (MP). Resulting references were screened for relevance by two independent authors (MP and VG/WD) based on title, title/abstract and full-text using Early Review Organizing Software (EROS, Institute of Clinical Effectiveness and Health Policy, Buenos Aires, Argentina, <http://www.eros-systematic-review.org>). In case of disagreement between authors or any doubt, references were included for further screening. An overview of all exclusion criteria per screening phase is provided in [Supplemental Information 2](#supp-4){ref-type="supplementary-material"}.

Studies were included for risk of bias assessment and meta-analysis when semi-quantitative histological scoring was used as outcome measure.

Study characteristics
---------------------

Study characteristics were extracted from the studies by MP. Basic information (author, year of publication), animal model characteristics (species, strain, sex, etc.), experimental characteristics (surgery, biomaterial, follow-up, etc.), cell characteristics (cell type, culture conditions, etc.) and outcome characteristics (macroscopic evaluation, histology and semi-quantitative histological scoring, etc.) were obtained.

Risk of bias assessment
-----------------------

The methodological quality was assessed for studies included in the meta-analysis. A risk of bias analysis was performed according to an adapted version ([@ref-48]) of the tool described by [@ref-32]. Selection, performance, detection and attrition bias were scored independently by MP and VG/WD using questions and a flowchart ([@ref-48]), where '-', '?' and '+', indicating low, unknown and high risk of bias. In case of differences between authors, results were discussed until consensus was reached. Unfortunately, 16 articles were published in Chinese and we did not have the resources to obtain certified translations of these articles. We were, however, able to successfully extract the data of these studies using Google Translate (<https://translate.google.com/>) and used the data in the meta-analysis. A sensitivity analysis was performed to evaluate the effect of language (exclusion of Chinese articles, see 'Meta-analysis').

Analysis preparations and meta-analysis
---------------------------------------

### Analysis preparations

Meta-analyses were performed for outcome measure semi-quantitative histology; data were used from studies that compared biomaterials with (experimental group) and without cells (control group). In general, these histological scoring systems and their components, extensively reviewed by [@ref-50], evaluate the degree of cartilage regeneration by scoring parameters like Safranin-O staining (which stains negatively charged glycosaminoglycans, an important component of cartilage tissue), surface integrity and cartilage thickness.

Outcome data (mean, standard deviation (SD) and number of animals) were extracted from the studies for all time points as follows: (1) numerical data from the text/tables, (2) graphical results by measuring the mean and SD using ImageJ (1.46r, National Institutes of Health USA), (3), boxplot results by recalculating from median, range and sample size to mean and SD ([@ref-34]), and (4) for results presented as mean and confidence interval (CI) per group, the following equation was used to recalculate CI to a standard deviation: $\documentclass[12pt]{minimal}
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}{}$SD=\sqrt{N}\times \frac{upper~limit-lower~limit}{3.92} $\end{document}$ for a 95% CI ([@ref-26]). When data were missing or unclear, authors were contacted to provide data. Studies were excluded from meta-analysis in case data could not be retrieved or remained unclear (e.g., missing SD, all SD's similar to corresponding mean, and histological scores exceeding maximum), unless data were sufficiently clear to make assumptions (i.e., group size and number of animals per time point and analyses, see [Supplemental Information 3](#supp-5){ref-type="supplementary-material"}). A sensitivity analysis was performed to evaluate the effect of assumptions (exclusion of articles with assumptions, see 'Meta-analysis'). Histological scoring systems describe the degree of cartilage regeneration with different scoring scales. To compare data from different studies, all data were converted to a 100% cartilage regeneration scale by dividing both the mean and SD by the maximum score of the scoring system and multiplying the outcome by 100%. In this systematic review, healthy tissue is represented as 100% cartilage regeneration. Lower percentages indicate less regenerated cartilage. When results of experimental groups could be combined per study (i.e., outcome of various biomaterials seeded with one cell type), we did so, followed the approach described in the Cochrane Handbook, table 7.7 ([@ref-26]), which means that we calculated a weighted average of the results with an appropriate standard deviation. Time points of treatment groups were combined using the same approach. The mean and corresponding standard error (SE) per treatment group were subsequently calculated per study.

### Meta-analysis

The main research question was: Is there an overall beneficial effect on cartilage regeneration of implanting biomaterials loaded with cells compared to acellular biomaterials?

We used a bivariate approach to model a random effects meta-analysis, i.e., separate outcomes for the control and experimental group were used with their respective SEs. The correlation between these two outcomes was modeled with a compound symmetry covariance matrix, as this resulted in a lower Akaike Information Criterion value than an unstructured covariance matrix.

To evaluate the effect of specific variables on treatment outcome for the experimental group (biomaterials loaded with cells), the following sub-questions were addressed: (1) Is there a difference between the use of stem cells and somatic (differentiated) cells (stem cells vs. somatic cells); (2) Do differences among various cell subgroups exist (e.g., chondrocytes vs. other cells); (3) Is there a difference between biomaterials loaded with cells which were not cultured *in vitro*, were expanded *in vitro* or were differentiated *in vitro* (during surgery vs. expansion, surgery vs. differentiation, and expansion vs. differentiation)? Results are depicted as % cartilage regeneration (95% CI: \[lower CI, upper CI\]. The mean difference (% \[95% CI\]) is presented as condition A--condition B. Based on a previous study, data of all time points were used ([@ref-48]). Subgroup analyses were performed in case subgroups consisted of more than five experimental groups in at least three studies. Most studies contained more than one experimental group, therefore the total number of studies and number of experimental groups (no. of studies/groups) is provided in the analysis. No adjustment for multiple testing was applied in analyses of sub-questions.

Sensitivity analyses were performed on the main research question to evaluate the effect of language (excluding Chinese articles, as the risk of bias for these articles was not investigated), and the effect of assumptions (excluding articles for which assumptions were made) in the meta-analysis.

SAS/STAT^®^ software version 9.2 for Windows, copyright© 2002--2008 by SAS Institute Inc., Cary, NC, USA, was used to perform statistical analyses. R software version 3.0.1 ([@ref-49]) with package meta ([@ref-53]) was used to create the funnel plot, which illustrates effect sizes of all studies versus their precision, and test for the asymmetry, using the method of moments estimator for the between study variation ([@ref-61]). *I*^2^ was used as a measure of heterogeneity. *I*^2^ measures the percentage of variability in treatment effect estimates that is due to between study heterogeneity rather than chance ([@ref-27]). If *I*^2^ is 0%, this suggests that the variability in the study estimates is entirely due to chance. If *I*^2^ is \>0% there might be other reasons for variability. ReviewManager ([@ref-60]) was used to create the forest plot.

Results
=======

Search and study inclusion
--------------------------

Searching PubMed and EMBASE databases for references regarding cartilage regeneration by implantation of cellular and acellular biomaterials in the knee and ankle joint in combination with bone marrow stimulation resulted in a total of 11,248 references (Pubmed 4,743, Embase 6,505). Removal of duplicates left 7,354 references. Screening by title and title/abstract resulted in exclusion of 6,744 references. Full-text of 610 studies resulted in 146 included studies. The full-text of some studies ([@ref-65]; [@ref-68]; [@ref-69]) could not be retrieved and these were excluded.

In the meta-analysis, studies were used which applied semi-quantitative histology as outcome measure, resulting in 117 included studies. A risk of bias assessment ([Fig. 2](#fig-2){ref-type="fig"}) was performed for 101 of 117 studies (excluding Chinese studies). [Supplemental Information 3](#supp-5){ref-type="supplementary-material"} provides an overview of all included studies after full-text screening, risk of bias assessment and meta-analysis, as well as detailed information regarding reasons for exclusion and assumptions made for certain studies. [Supplemental Information 4](#supp-6){ref-type="supplementary-material"} contains the reference list and abbreviations of [Supplemental Information 3](#supp-5){ref-type="supplementary-material"} studies.

![PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-analysis) flowchart of the systematic search of literature.\
Of the 117 studies included for the meta-analysis, a risk of bias assessment was performed for 101 studies, excluding Chinese articles.](peerj-05-3927-g002){#fig-2}

Study characteristics
---------------------

A large variation between studies was observed regarding animal model characteristics (species, strain, sex, etc.), experimental characteristics (surgery, biomaterial, follow-up, etc.), cell characteristics (cell type, culture conditions, etc.) and outcome characteristics (macroscopic evaluation, histology and semi-quantitative histological scoring, etc.), as can be appreciated from [Supplemental Information 3](#supp-5){ref-type="supplementary-material"}. Various animal species were used including rabbit, dog, sheep, pig, rat, horse, minipig, goat and macaques. A large range was found in animal age, e.g., the age of rabbits ranged from six weeks to \>2 years. Small animals were generally younger (in the range of months) compared to larger animals (in the range of years). In many studies, no detailed information was provided regarding the animal's absolute age, but merely e.g., adult or mature.

The method for bone marrow stimulation was mostly subchondral drilling (142 studies), where only four studies used microfracture. Defects were created at various locations (trochlea, condyles, femur and intercondylar fossa) and with diverse dimensions (e.g., for rabbits: diameter 4--7 mm and depth 0.8--9 mm).

Implanted biomaterials were prepared from natural (e.g., alginate and collagen), synthetic (e.g., poly(lactic-coglycolic acid) and polycaprolactone) or mixtures of natural and synthetic materials. In 27 studies biologics, such as bone morphogenetic protein 2 and transforming growth factor beta, were loaded in the biomaterials. Different cell types were applied, including chondrocytes, bone marrow-derived mesenchymal stem cells (BM-MSCs), bone marrow-derived progenitor cells, synovium-derived stem cells (SD-MSCs), bone marrow-derived mononuclear cells, adipose-derived stem cells, adipose-derived stromal vascular fraction cells, endothelial progenitor cells, embryonic stem cells, umbilical cord blood stem cells, fibroblasts, and periosteal cells, while in some studies undefined cell populations like bone marrow aspirate concentrate were used. Cells were either seeded directly after harvesting on biomaterials and implanted in the created defect or cultured *in vitro* to expand and/or differentiate the cells, followed by seeding on biomaterials and implantation. *In vitro* differentiation was performed with cells cultured in monolayer (without biomaterials), followed by seeding of the cells onto the biomaterials and implantations, or by directly culturing the cells on biomaterials prior to implantation.

In most studies, short-term cartilage regeneration was investigated: the follow-up time was generally less than 6 months with a maximum follow-up of 12 months.

Risk of bias assessment
-----------------------

The methodological quality was assessed for all studies included in the meta-analysis except Chinese articles. The overview of the results in [Fig. 3](#fig-3){ref-type="fig"} indicates a general lack of information regarding the experimental setup of the studies, limiting the assessment of the actual risk of bias. Please see [Supplemental Information 5](#supp-7){ref-type="supplementary-material"} for all scores per individual study.

![Results of the risk of bias analysis.\
Low, unknown or high risk of bias are presented in green, orange and red, respectively, where the percentages indicate the percentage of studies scoring low, unknown or high risk of bias of the total number of investigated studies per question. Low risk of bias was mainly found for addressing incomplete outcome data and baseline characteristics at the moment of surgical intervention. Unknown risk of bias was generally the result of limited details described in the studies regarding the experimental set-up. High risk of bias was only occasionally scored. Questions 4--6 are not depicted graphically, but are described and explained in [Supplemental Information 4](#supp-6){ref-type="supplementary-material"}.](peerj-05-3927-g003){#fig-3}

In the assessed studies, details regarding the application and method of randomization (Q1) were generally lacking. As a result, assessment of the actual risk of selection bias was practically impossible. Assessment of the actual risk of bias due to differences in baseline characteristics was difficult since no details regarding randomization were described. Differences may have been present in load-bearing between implantation sites (Q2.1) and age, sex and weight of animals (Q2.2). In most studies, few differences were found between animals at the moment of surgical intervention since animals were treated similarly (Q2.3). Details regarding blinding of experimental conditions at the moment of implantation were generally not provided, which may have resulted in bias (Q3). Random housing of animals was generally not (well) described (Q4). Caregivers and/or investigators did not know which intervention each animal received during the experiment (Q5). No details were presented regarding the random selection of animals for outcome assessment (Q6). The method of blinding during analysis, however, was well described in most studies (Q7). Incomplete outcome data were identified or described in a few studies only, which resulted in studies with high risk of bias (Q8). Generally, most studies lacked reporting of important details and therefore adequate assessment of the actual risk of bias was difficult.

Data synthesis
--------------

Semi-quantitative histological scores were used as outcome data to compare biomaterials with cells (experimental group) and without cells (control group) and to address sub-questions related to the use of type of cells and culture conditions. An overview of all meta-analysis results is provided in [Table 1](#table-1){ref-type="table"}; an overview of all raw data is given in [Supplemental Information 6](#supp-8){ref-type="supplementary-material"}.

10.7717/peerj.3927/table-1

###### Overview meta-analysis results; the effect on cartilage regeneration of (1) the addition of cells to biomaterials, (2) loading of stem cells vs. somatic cells, (3) loading of specific cell types, e.g., chondrocytes vs. all cells except chondrocytes, and (4) culture conditions.

The total number of studies and number of groups included in the meta-analysis are depicted (studies may have \>1 experimental group, no. of studies/groups). Results are presented on a 100% cartilage regeneration scale, where 100% indicates 'maximum' cartilage regeneration. The addition of cells to biomaterials significantly improved cartilage regeneration compared to acellular biomaterials. The use of stem cells or somatic cells resulted in comparable cartilage regeneration. Cartilage regeneration was significantly lower for biomaterials seeded with adipose-derived stem cells compared to other cell types. Cartilage regeneration was not affected by the method of cell manipulation.

![](peerj-05-3927-g005)

  Meta-analysis                     No. of studies/groups                                                   Subgroups                                  Cartilage regeneration (% \[95% CI)\]   Mean difference (% \[95% CI\])
  --------------------------------- ----------------------------------------------------------------------- ------------------------------------------ --------------------------------------- --------------------------------
  1\. Overall effect                98/265                                                                  Cellular scaffolds                         61.5 \[58.5--64.5\]                     18.6% \[15.2--22.0\]
  98/208                            Acellular scaffolds                                                     43.0 \[40.0--46.0\]                        ***p*** \< **0.0001**                   
  2\. Stem cells or somatic cells   57/148                                                                  Stem cells                                 61.5 \[58.1--65.0\]                     −1.28 \[−6.5--4.0\]
  36/101                            Somatic cells                                                           62.8 \[58.5--67.1\]                        *p* = 0.622                             
  3\. Type of cells                 30/81                                                                   Chondrocytes                               63.6 \[58.1--69.0\]                     2.7 \[−3.4--8.9\]
                                                                                                                                                       *p* = 0.373                             
  44/117                            Bone marrow-derived MSCs                                                61.5 \[57.1--65.9\]                        −0.3 \[−6.0--5.4\]                      
                                                                                                                                                       *p* = 0.919                             
  3/6                               Synovium-derived MSCs                                                   7.4 \[36.7--98.2\]                         −6.0 \[−8.5--20.5\]                     
                                                                                                                                                       *p* = 0.412                             
  11/19                             Adipose-derived stem cells                                              56.3 \[49.9--62.6\]                        −5.9 \[−11.3--−0.4\]                    
                                                                                                                                                       ***p*** = **0.036**                     
  8/14                              Bone marrow aspirate                                                    54.7 \[39.8--69.6\]                        −7.6 \[−20.5--5.2\]                     
                                                                                                                                                       *p* = 0.239                             
  3/7                               Bone marrow-derived mononuclear cells                                   74.1 \[27.9--100.0\]                       12.9 \[−8.6--34.3\]                     
                                                                                                                                                       *p* = 0.238                             
  4\. Cell manipulation             14/27                                                                   During surgery: harvesting, implantation   58.9 \[51.3--66.5\]                     Surgery vs. Expansion
                                                                                                                                                       −2.4 \[−10.8--5.9\]                     
                                                                                                                                                       *p* = 0.564                             
  59/180                            Expansion: harvesting, expansion *in vitro*, implantation               61.4 \[57.6--65.1\]                        Surgery vs. Differentiation             
                                                                                                                                                       −4.2 \[−13.5--5.1\]                     
                                                                                                                                                       *p* = 0.374                             
  27/58                             Differentiation: harvesting, differentiation *in vitro*, implantation   63.1 \[57.6--68.6\]                        Expansion vs. Differentiation           
                                                                                                                                                       −1.7 \[−8.2--4.7\]                      
                                                                                                                                                       *p* = 0.594                             

Data are presented as the effect (%) with 95% CI, where 100% cartilage regeneration represents healthy tissue and lower percentages indicate less regenerated cartilage tissue.

### Overall effect implantation of cellular and acellular biomaterials

The meta-analysis indicates that implantation of cellular and acellular biomaterials resulted in 61.5% (95% CI \[58.5--64.5\]) and 43.0% (95% CI \[40.0--46.0\]) cartilage regeneration, respectively. The addition of cells to biomaterials significantly improved cartilage regeneration by 18.6% (95% CI \[15.2--22.0\], *p* \< 0.0001). An overview of results for each individual study is displayed in the forest plot ([Supplemental Information 7](#supp-9){ref-type="supplementary-material"}), presenting improved cartilage regeneration by loading biomaterials with cells in 66 studies, similar cartilage regeneration in 30 studies, and a negative effect on cartilage regeneration in two studies. The heterogeneity (*I*^2^) for the comparison between cellular and acellular biomaterials was very high (99.4% (95% CI \[99.3%--99.4%\])).

### Stem cells and somatic cells

No significant differences (*p* = 0.622) were found between biomaterials loaded with stem cells (61.5% (95% CI \[58.1--65.0\])) and somatic cells (62.8% (95% CI \[58.5--67.1\])).

### Cell type

Biomaterials were loaded with various cell types. Subgroup analyses were only performed when subgroups consisted of more than five experimental groups in at least 3 studies. Seeding biomaterials with adipose-derived stem cells significantly decreased cartilage regeneration, while no other significant differences were observed ([Table 1](#table-1){ref-type="table"}). Only for scaffolds seeded with adipose-derived stem cells (ADSCs), reduced cartilage regeneration was found (56.3% (95% CI \[49.9--62.6\])) compared to cellular scaffolds. However, cartilage regeneration using ADSCs-seeded scaffolds still improved regeneration compared to acellular scaffolds.

### Cell manipulation

Comparing differences in cartilage regeneration between biomaterials loaded with cells which were not cultured *in vitro* (implanted immediately after harvesting of cells) or were expanded and/or differentiated *in vitro* indicated that cell manipulation did not affect cartilage regeneration ([Table 1](#table-1){ref-type="table"}).

### Sensitivity analyses

To investigate the robustness of the meta-analysis, sensitivity analyses were performed regarding the overall effect of the addition of cells to biomaterials. The overall outcome effect for cellular scaffolds was not notably affected by the exclusion of studies (1) with assumptions (2) or written in Chinese (no risk of bias assessment performed). Also for acellular biomaterials, the exclusion of these studies had no effect on cartilage regeneration.

### Publication bias

Publication bias was assessed for all studies included in the meta-analysis comparing cartilage regeneration using acellular versus cellular biomaterials. Although the funnel plot ([Fig. 4](#fig-4){ref-type="fig"}) is rectangular in shape, no major asymmetry was observed, giving no indication for publication bias (*p*-value 0.866).

![Funnel plot of the studies included in the meta-analysis comparing cartilage regeneration using cell-laden and acellular biomaterials.\
No substantial asymmetry was found.](peerj-05-3927-g004){#fig-4}

Discussion
==========

Bone marrow stimulation can be applied to induce cartilage regeneration. Despite therapy, the formed neotissue generally consists of fibrous cartilage, which lacks mechanical and biological properties of native tissue ([@ref-16]). Therefore, microfracture results in temporary clinical improvement only ([@ref-51]). To regenerate more durable cartilage tissue, regenerative medicine and tissue engineering may offer a promising addition to bone marrow stimulation by the implantation of scaffolds, which can act as a template to guide and stimulate cartilage regeneration ([@ref-15]). In a previous systematic review, the quality of newly formed cartilage in animals was improved by the implantation of biomaterials after bone marrow stimulation, which was further enhanced by loading biomaterials with biologics ([@ref-48]). The aim of this systematic review was (a) to provide a comprehensive and systematic overview of all current literature regarding animal studies on cartilage regeneration using cellular versus acellular biomaterials and to identify knowledge gaps, (b) to assess the efficacy of cartilage regeneration using cellular versus acellular biomaterials and to investigate the effect of various parameters (i.e., stem/somatic cells, cell source, cell culture conditions), (c) to gain insight in the methodological quality of animal studies, and (d) to improve the design of future animal models and eventually clinical trials.

In animal studies, the implantation of cellular biomaterials in animal models significantly improved cartilage regeneration by 18.6% compared to acellular biomaterials. Seeding of cells is a major component of the tissue engineering paradigm, which may stimulate healing by the production of many bioactive components. Therefore, the addition of cells to biomaterials enhanced the regenerative process ([@ref-64]). The heterogeneity (*I*^2^) for the main research question and subgroup analyses was very high. Results should therefore be interpreted with caution, especially for subgroup analyses with a limited number of studies. Further clinical studies are required to assess the potential beneficial effect of cellular biomaterials versus acellular biomaterials in patients. [@ref-42] published promising results of a multicenter clinical phase III retrospective cohort study in which patients were treated with an implant consisting of autologous chondrocytes grown on Hyalograft C, a hyaluronic acid derivative, with a 3-year follow-up. Assessment indicated major clinical improvements and hyaline-like cartilage for the majority of biopsies.

In a subgroup analysis, no significant differences were found between somatic cells and stem cells. Differences were found between various cell types. Adipose-derived stem cells (ADSCs) reduced cartilage regeneration in the subgroup analysis. However, cartilage regeneration using biomaterials seeded with ADSCs was still superior to biomaterials without cells. As compared to other cell types, the origin of ADSCs from fatty tissue may have resulted in significantly reduced cartilage regeneration compared to cells derived from cartilage or subchondral bone. MSCs and chondrocytes have distinct advantages. MSCs are not limited by donor-site morbidity and matrix production after expansion *in vitro* ([@ref-6]), can be harvested from numerous sources, maintain their multipotency after expansion *in vitro*, can differentiate into chondrocytes that produce cartilage matrix and may suppress proinflammatory cytokines by their immunoregulatory properties. Chondrocytes on the other hand do not terminally differentiate after chondrogenic differentiation, which results in bone formation ([@ref-6]), and are more easy to manipulate ([@ref-20]). In clinical trials, the addition of MSCs or chondrocytes to biomaterials resulted in comparable cartilage regeneration ([@ref-45]; [@ref-40]). In this study no subgroup analysis was performed to investigate the culture of cell-loaded scaffolds in bioreactors. [@ref-6] described the beneficial effects of culturing cell-loaded scaffolds in bioreactors with mechanical loading protocols, as these scaffolds more closely resembled the native compressive properties of cartilage tissue and as the applied force steered the location and alignment of cartilage matrix deposition by chondrocytes ([@ref-6]).

Study characteristics showed a large heterogeneity between studies due to differences in animal model, performed surgery, implanted biomaterial and follow-up period. To reduce the influence of possible confounding parameters, we excluded studies using healthy animals in which created defects were not filled during the first surgery and osteoarthritis animal models, despite their greater relevance for future applications to treat patients with osteoarthritis.

Various outcome measures were used to investigate cartilage regeneration, including MRI, macroscopic and histological evaluation (more extensively discussed in [@ref-48]). We selected data from semi-quantitative histological scoring systems as outcome measure, because histological scores are frequently used and allow for quantitative comparisons between studies. However, different scoring systems are available (extensively reviewed by Rutgers et al. ([@ref-32])) that assess different processes, e.g., cartilage regeneration only, cartilage and subchondral bone regeneration, and additional biomaterial degradation. Not discriminating between these parameters may be considered as a limitation, but usage of all scoring systems may provide an extensive and complete overview of all aspects affecting the regenerative process. Additionally, evaluation of cartilage regeneration using semi-quantitative histological scoring may still be observer-dependent and subjective, possibly inducing observer (detection) bias. Therefore, it may be better to combine histological scores with biochemical parameters and biomechanical properties, but the ideal combination of outcome parameters remains unknown ([@ref-32]).

The methodological quality assessment was performed to evaluate the experimental designs and reliability of the results of included studies. The methodological quality (internal validity) is of great importance since a low methodological quality may result in an overestimation or underestimation of the effect size ([@ref-25]). No studies were included in or excluded from the meta-analysis based on methodological quality assessment results. Generally, the possibility of assessing the actual risk of bias was limited due to the absence of important details regarding the experimental set-up in most studies and method of randomization. It may be that the animal studies were performed well, but that experimental designs were only reported poorly ([@ref-31]). For the analysis of the histological sections, however, most studies described that sections were randomized and that outcome assessors were blinded. Detection/observer bias may be introduced in case blinding was not performed and can result in an overestimation of the actual effect of the therapy ([@ref-5]). The overall validity of the study results may be impaired by bias due to the lack of blinding and randomization ([@ref-4]; [@ref-28]). Reporting of animal studies may be improved by using standardized protocols, including the ARRIVE guidelines ([@ref-37]) or golden standard publication checklist ([@ref-30]).

A high translational value of animal studies is crucial to take treatments forward to clinical practice. Therefore, validated and predictive animal models are required. Many challenges and limitations are associated with the use of animal models for cartilage defects. [@ref-12] and [@ref-1] extensively described strengths and shortcomings of different animal models related to e.g., joint size, cartilage thickness, defect size, intrinsic healing potential and animal maturity, in comparison to lesions in clinical studies. In most animal experiments, the follow-up period was maximally six months, while in patients clinical improvements are generally observed up to 1.5--3 years after microfracture surgery ([@ref-29]; [@ref-62]). The translational value and considerations to select animal models were extensively discussed before ([@ref-48]).

Improved reporting of animal studies is required in future studies and studies should strive to resemble the clinical situation to facilitate translation. For clinical application of new regenerative medicine and tissue engineering strategies, including the use of biomaterials, biologics and cells, the effectiveness needs to be proven both in animal models and clinical studies ([@ref-14]). Moreover, the cost-effectiveness of new interventions in clinical practice may be assessed using early health economic models ([@ref-19]). Considerations for the addition of cells to biomaterials are of great importance and limitations (including donor-site morbidity, cell culture costs, regulatory issues, limited off the shelf availability, and potential multiple-stage surgical procedures ([@ref-48]; [@ref-22])) should be weighed against potentially superior cartilage regeneration by applying cellular biomaterials. Difficulties in controlling cell culture and the development of novel materials stimulating tissue regeneration may justify the use of acellular biomaterials. Future research focusing on biomaterials properties, source and manipulation of cells, and possibly patient profiling, may allow selection of the best treatment for each individual patient ([@ref-38]).

Conclusion
==========

This systematic review and meta-analysis provides an extensive overview of all animal studies applying regenerative medicine and tissue engineering approaches to regenerate articular cartilage by implantation of cellular versus acellular biomaterials after applying bone barrow stimulation. Cartilage regeneration was more effective by implantation of cellular biomaterials compared to acellular biomaterials. This study together with a previous study on the beneficial properties of scaffolds and growth factors implies that all components of the tissue engineering paradigm can be valuable for improved regeneration of articular cartilage.
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